Literature DB >> 11819357

Segmental transcatheter arterial embolization for primary hepatocellular carcinoma.

Li Li, Pei-Hong Wu, Jin-Qing Li, Wei-Zhang Zhang, Hao-Gao Lin, Ya-Qi Zhang.   

Abstract

AIM:To evaluate the therapeutic effects of segmental transcatheter arterial embolization for primary hepatocellular carcinoma, and to recognize the menifestation and clinical value of lipiodol overflow into portal veins surrounding the tumors.
METHODS: A total of 50 cases of nonresectable primary hepatocellular carcinoma underwent segmental transcatheter arterial embolization. Two methods of superselective segmental catheterization were used, one was the method of wire-guiding, and the other the technic of co-axial infusion catheter.
RESULTS: The 1-, 2-, 3- and 4-year cumulative survival rates of 50 cases with segmental transcatheter arterial embolization for primary hepatocellular carcinoma were 83.8%, 65.4%, 42.9% and 24.5% respectively. The in cidence of the lipiodol overflow into portal veins was 64%. The overflow of lipiodol intoportal veins, represented as 3-5 grade branches of portal veins visualized by lipiodol, was star-like or tree-like , and there was a relatively large vessel in the center surrounded with radicalized small branches of vessels.
CONCLUSION: The lipiodol overflow into portal veins was one of the signs of complete embolization for tumors, and may play a partial role in embolizating the portal venous supply for hepatocellular carcinoma.

Entities:  

Year:  1998        PMID: 11819357      PMCID: PMC4723440          DOI: 10.3748/wjg.v4.i6.511

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

1.  Outcome of localized hepatocellular carcinoma treated with segmental arterioportal chemoembolization.

Authors:  H Nakamura; H Oi; S Hori; Y Takayasu; S Furui; S Sawada; T Kozuka
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Iodized oil in the portal vein after arterial embolization.

Authors:  H Nakamura; T Hashimoto; H Oi; S Sawada
Journal:  Radiology       Date:  1988-05       Impact factor: 11.105

3.  Iodized oil injected in the hepatic artery will enter the portal vein.

Authors:  Z Kan
Journal:  J Vasc Interv Radiol       Date:  1994 May-Jun       Impact factor: 3.464

4.  Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings.

Authors:  N Matsuo; H Uchida; H Sakaguchi; K Nishimine; Y Nishimura; S Hirohashi; H Ohishi
Journal:  Semin Oncol       Date:  1997-04       Impact factor: 4.929

5.  Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma.

Authors:  K N Khan; K Nakata; Y Kusumoto; M Shima; N Ishii; T Koji; S Nagataki
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

6.  In vivo microscopy of the liver after injection of Lipiodol into the hepatic artery and portal vein in the rat.

Authors:  Z Kan; K Ivancev; I Hägerstrand; V P Chuang; A Lunderquist
Journal:  Acta Radiol       Date:  1989 Jul-Aug       Impact factor: 1.990

7.  Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue.

Authors:  N Matsuo; H Uchida; K Nishimine; S Soda; M Oshima; H Nakano; N Nagano; Y Nishimura; T Yoshioka; Q Guo
Journal:  J Vasc Interv Radiol       Date:  1993 Jul-Aug       Impact factor: 3.464

8.  Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.

Authors:  K Nishimine; H Uchida; N Matsuo; H Sakaguchi; S Hirohashi; Y Nishimura; Q Guo; H Ohishi; N Nagano; T Yoshioka
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate.

Authors:  O Matsui; M Kadoya; J Yoshikawa; T Gabata; T Takashima; H Demachi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

  9 in total
  19 in total

1.  DSA analysis of hepatic arteriovenous fistula concurrent with hepatic cancer and its clinical significance.

Authors:  Wei-Ping Guo; Hong-Xin Zhang; Zhi-Min Wang; Yi-Qing Wang; Dai-Hui Ni; Wen-Xian Li; Yan Guan
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Percutaneous transsplenic embolization of esophageal and gastrio-fundal varices in 18 patients.

Authors:  G Q Gong; X L Wang; J H Wang; Z P Yan; J M Cheng; S Qian; Y Chen
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

3.  Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats.

Authors:  Jun Qian; Daryusch Vossoughi; Dirk Woitaschek; Elsie Oppermann; Wolf O Bechstein; Wei-Yong Li; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

4.  Simultaneous injection of autologous mononuclear cells with TACE in HCC patients; preliminary study.

Authors:  Alaa Ismail; Ahmed AlDorry; Mohammed Shaker; Reda Elwekeel; Khaled Mokbel; Doaa Zakaria; Anas Meshaal; Firas Zahr Eldeen; Abdulhafez Selim
Journal:  J Gastrointest Cancer       Date:  2011-03

5.  DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line.

Authors:  Zhao-Chong Zeng; Guo-Liang Jiang; Guo-Min Wang; Zhao-You Tang; Walter J Curran; George Iliakis
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 6.  Combined interventional therapies of hepatocellular carcinoma.

Authors:  Jun Qian; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.

Authors:  Fu-Hua Yan; Kang-Rong Zhou; Jie-Min Cheng; Jian-Hua Wang; Zhi-Ping Yan; Reng-Rong Da; Jia Fan; Yuan Ji
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

8.  Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma.

Authors:  Wu Ji; Jie-Shou Li; Ling-Tang Li; Wu-Hong Liu; Kuan-Sheng Ma; Xiang-Tian Wang; Zhen-Ping He; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

9.  Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study.

Authors:  Rodolfo Sacco; Marco Bertini; Pasquale Petruzzi; Michele Bertoni; Irene Bargellini; Giampaolo Bresci; Graziana Federici; Luigi Gambardella; Salvatore Metrangolo; Giuseppe Parisi; Antonio Romano; Antonio Scaramuzzino; Emanuele Tumino; Alessandro Silvestri; Emanuele Altomare; Claudio Vignali; Alfonso Capria
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

10.  Study on hepatocellular carcinoma-associated hepatic arteriovenous shunt using multidetector CT.

Authors:  Ming-Yue Luo; Hong Shan; Zai-Bo Jiang; Lu-Fang Li; Hui-Qing Huang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.